caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1558455154

David Baskin

Internal MedicineNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,649
Unique beneficiaries
—
Total services
2,693
Distinct HCPCS
14
Medicare payment
$163K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 7,864 Internal Medicine providers in NY — top quintile (cohort median 552).
REFERRAL NETWORK

Where David Baskin's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 13 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
ST LUKES ROOSEVELT HOSPITAL CENTER101267
Martin Baskin
Internal Medicine · New York, NY
50124
Steven Plotycia
Ophthalmology · New York, NY
3654
Theodore Antonetz
Podiatry · Nyc, NY
3363
ENZO CLINICAL LABS, INC.3257
Naomi Freistat
Podiatry · New York, NY
2872
LENOX HILL HOSPITAL2559
TRANSCARE NEW YORK, INC.1542
NPI 11745540421426
Francisco Delara
Diagnostic Radiology · New York, NY
1422
Patrick Kang
Diagnostic Radiology · New York, NY
1231
Bette Kim
Cardiology · New York, NY
1226
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
3,671
Beneficiaries
—
Total drug cost
$378K
Distinct drugs
85
Brand share
20.2%
Top prescribed drugs
Atorvastatin Calcium280 claims
Rosuvastatin Calcium190 claims
Zolpidem Tartrate165 claims
Amlodipine Besylate164 claims
Levothyroxine Sodium159 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$2K
Payment records
104
By payment type
Food and Beverage$2K